Literature DB >> 7439258

Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.

A Jørgensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7439258     DOI： 10.1007/bf00561395

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  The comparative pharmacology of flupenthixol and some reference neuroleptics.

Authors:  I M Nielsen; V Pedersen; M Nymark; K F Franck; V Boeck; B Fjalland; A V Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

2.  Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds.

Authors:  A Jorgensen; C G Gottfries
Journal:  Psychopharmacologia       Date:  1972

3.  A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum.

Authors:  A Jørgensen
Journal:  Life Sci       Date:  1978-10-16       Impact factor: 5.037

4.  Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.

Authors:  D H Wiles; M G Gelder
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

5.  Plasma-fluphenazine concentrations after injection of long-acting esters.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

6.  Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.

Authors:  J A Stauning; L Kirk; A Jøorgensen
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

7.  Pharmacokinetics of amitriptyline infused intravenously in man.

Authors:  A Jorgensen; V Hansen
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

8.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

9.  Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.

Authors:  A Jrgensen; K F Overø
Journal:  Acta Psychiatr Scand Suppl       Date:  1980

10.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321
View more
  14 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Dopamine in the nucleus accumbens modulates the memory of social defeat in Syrian hamsters (Mesocricetus auratus).

Authors:  C L Gray; A Norvelle; T Larkin; K L Huhman
Journal:  Behav Brain Res       Date:  2015-02-23       Impact factor: 3.332

Review 3.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

Review 4.  Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.

Authors:  S R Marder; J W Hubbard; T Van Putten; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.

Authors:  Ahmed Abdelbary; Ehab R Bendas; Afaf A Ramadan; Dalia A Mostafa
Journal:  AAPS PharmSciTech       Date:  2014-08-21       Impact factor: 3.246

Review 6.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

8.  Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.

Authors:  T R Barnes; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.

Authors:  A Jørgensen; J Andersen; N Bjørndal; S J Dencker; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 10.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.